The Centers for Disease Control and Prevention was set to meet with advisers Thursday to discuss possible restrictions on Johnson & Johnson’s COVID-19 vaccine due to ongoing concerns about blood clots, particularly among women.
Federal officials temporarily halted use of the single dose J&J vaccine in April to study six women who had experienced blood clots after getting vaxxed. The government ruled that the rewards far outweighed the risks associated with the shot, and usage of the vaccine resumed within days with a new warning label.-- More...
